HAEMOPHILIA A WITH INHIBITORS
Clinical trials for HAEMOPHILIA A WITH INHIBITORS explained in plain language.
Never miss a new study
Get alerted when new HAEMOPHILIA A WITH INHIBITORS trials appear
Sign up with your email to follow new studies for HAEMOPHILIA A WITH INHIBITORS, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New drug Mim8 aims to prevent bleeds in hemophilia a patients
Disease control OngoingThis study tests a new medicine called Mim8 in people with hemophilia A, a condition where blood does not clot properly. Mim8 helps replace a missing clotting factor to prevent bleeding episodes. About 451 participants will receive injections over up to 5.5 years, and researchers…
Matched conditions: HAEMOPHILIA A WITH INHIBITORS
Phase: PHASE3 • Sponsor: Novo Nordisk A/S • Aim: Disease control
Last updated May 26, 2026 07:58 UTC
-
New daily jab cuts bleeds for hard-to-treat hemophilia patients
Disease control OngoingThis study tested a new daily injection called concizumab for people with hemophilia A or B whose bodies have developed inhibitors that block standard treatments. The goal was to see if concizumab could safely prevent bleeding episodes. About 134 participants either started conci…
Matched conditions: HAEMOPHILIA A WITH INHIBITORS
Phase: PHASE3 • Sponsor: Novo Nordisk A/S • Aim: Disease control
Last updated May 22, 2026 14:02 UTC